News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Bitcoin fell below $68,000 as a rebound stalled, putting the largest cryptocurrency on track for a fifth straight monthly decline.
  • Ether and XRP also posted notable monthly pullbacks, signaling broader crypto market weakness.
  • MARA Holdings said it is pivoting toward AI data centers, prompting a rare positive market reaction.
  • China's Politburo called for proactive fiscal and moderately accommodative monetary measures to stabilize employment, businesses and markets.
  • Central bankers in the US, Europe and Japan publicly resisted political pressure to defend independence, raising governance and market credibility concerns.
  • The RealReal reported higher take-rates and operating leverage, positioning EBITDA gains and a mid-term trade toward its 52-week high.

Latest Articles

Greenwave Names Chelsea Pullano as CFO; Shares Slip in After-Hours Trade

Greenwave Names Chelsea Pullano as CFO; Shares Slip in After-Hours Trade

Greenwave Technology Solutions Inc. saw its stock decline in after-hours trading following the announcement that Chelsea Pullano will take over as chief financial officer effective Feb. 5, 2026. The appointment is linked to a services agreement with MACK Financial Solutions, which will provide financial and SEC reporting support under a contract da…

Marwynn Shares Jump After Plan to Acquire Majority Stake in DJ Mex

Marwynn Shares Jump After Plan to Acquire Majority Stake in DJ Mex

Marwynn Holdings Inc. disclosed a non-binding letter of intent to acquire a 51% equity interest in DJ Mex Corp., a U.S.-based electronic waste specialist. The announcement prompted a 20.6% rise in Marwynn's stock in after-hours trading. The proposed deal would integrate DJ Mex into Marwynn's EcoLoopX reverse supply-chain platform, preserving DJ Mex…

BMO Trims Datadog Price Target to $165, Keeps Outperform Rating

BMO Trims Datadog Price Target to $165, Keeps Outperform Rating

BMO Capital lowered its 12-month price target on Datadog to $165 from $170 while retaining an Outperform rating, citing valuation compression rather than company-specific weaknesses. The move follows Datadog's fiscal 2026 revenue guidance and recent fourth-quarter 2025 results that beat estimates, and comes amid mixed repositioning of targets from …

Bought the AI Dip - Buying Microsoft for a 6-Month Run

Bought the AI Dip - Buying Microsoft for a 6-Month Run

Microsoft pulled back into the low-$400s and the dip looks buyable for a long-term trade. The company still delivers high return on equity, strong free cash flow and durable cloud/AI revenue streams. My plan: enter near current levels, limit downside with a firm stop, and target a recovery toward the 50-day SMA and the next resistance band over the…

Stifel Starts Coverage on BridgeBio Oncology with Buy and $23 Target

Stifel Starts Coverage on BridgeBio Oncology with Buy and $23 Target

Stifel has begun coverage of BridgeBio Oncology Therapeutics, Inc (NASDAQ: BBOT) with a Buy rating and a $23.00 price target. The firm's analyst, Laura Prendergast, highlighted the company's focus on RAS and PI3Kα oncogenic drivers using distinct mechanisms intended to address safety and resistance limitations seen in earlier drugs. Stifel pointed …

Justice Department Asks U.S. Attorneys for 'Most Egregious' Judicial Actions as Possible Basis for Congressional Review

Justice Department Asks U.S. Attorneys for 'Most Egregious' Judicial Actions as Possible Basis for Congressional Review

The Justice Department has requested that all 93 U.S. Attorneys provide what it calls the "most egregious" examples of judicial decisions that obstruct the Trump administration's agenda, a step the department says is intended to help Congress consider whether to exercise its oversight and impeachment authorities. The move reflects rising friction b…

RBC Lifts UDR Price Target to $39 After Strong Rental Spread Outlook

RBC Lifts UDR Price Target to $39 After Strong Rental Spread Outlook

RBC Capital raised its price objective on UDR, Inc. to $39.00 from $38.00 while maintaining a Sector Perform rating, citing a stronger-than-expected rental spread outlook for the first quarter of 2026 and an atypical earnings update relative to apartment peers. The firm highlighted UDR's asset dispositions and share repurchase activity amid market …

Evercore Lowers MetLife Target to $95 After Q4 Results; Rating Unchanged

Evercore Lowers MetLife Target to $95 After Q4 Results; Rating Unchanged

Evercore ISI cut its price target on MetLife to $95 from $97 following the insurer's fourth-quarter 2025 results and 2026 outlook, but left its "In Line" rating and 2026-2027 EPS forecasts unchanged. The modest 2% target reduction reflects an accounting change tied to real estate and does not alter Evercore's view of free cash flow materially, acco…

AGL Energy Tightens Full-Year Profit Guidance as First-Half Earnings Slip

AGL Energy Tightens Full-Year Profit Guidance as First-Half Earnings Slip

AGL Energy narrowed its full-year underlying net profit after tax guidance, citing improved consumer margins and lower operating costs, while reporting a 6.4% decline in first-half underlying profit to A$353 million. The revised forecast midpoint sits above analyst consensus, and the company is targeting A$50 million of sustainable net operating co…

Energy Transfer: Positioning for an AI-Driven Natural Gas Lift

Energy Transfer: Positioning for an AI-Driven Natural Gas Lift

Energy Transfer (ET) trades cheap on EV/EBITDA and P/E, yields ~7.3%, and sits squarely in the path of rising natural gas demand driven by winter weather and incremental load from AI data centers. This trade idea lays out an entry at $18.12, a stop at $17.00 and a target of $20.50 over a mid-term (45 trading days) horizon with clear catalysts and r…

Gilead Q4 Sales and Profit Slightly Top Estimates as 2026 Guidance Lands at Low End of Street Expectations

Gilead Q4 Sales and Profit Slightly Top Estimates as 2026 Guidance Lands at Low End of Street Expectations

Gilead Sciences reported fourth-quarter adjusted earnings per share of $1.86 on revenue of $7.9 billion, modestly above analyst estimates. Sales of the twice-yearly HIV prevention injection Yeztugo and the HIV treatment Biktarvy both beat Wall Street forecasts for the quarter. For 2026, management set guidance that sits at the lower bound of analys…